Henry Schein (NASDAQ:HSIC) Stock Rating Lowered by ValuEngine

ValuEngine downgraded shares of Henry Schein (NASDAQ:HSIC) from a sell rating to a strong sell rating in a report published on Monday, ValuEngine reports.

HSIC has been the subject of several other research reports. Zacks Investment Research lowered shares of Henry Schein from a hold rating to a sell rating and set a $71.00 target price for the company. in a report on Wednesday, November 6th. Barrington Research reiterated a buy rating and set a $75.00 price target on shares of Henry Schein in a report on Wednesday, November 6th. TheStreet upgraded shares of Henry Schein from a c+ rating to a b rating in a report on Monday, October 14th. Robert W. Baird lowered shares of Henry Schein from an outperform rating to a neutral rating in a research report on Thursday, January 2nd. Finally, Cleveland Research reissued a hold rating on shares of Henry Schein in a research note on Friday, November 1st. Five equities research analysts have rated the stock with a sell rating, seven have given a hold rating and five have assigned a buy rating to the stock. The stock has an average rating of Hold and a consensus target price of $70.50.

NASDAQ HSIC traded up $0.61 on Monday, hitting $72.12. 42,675 shares of the stock were exchanged, compared to its average volume of 892,431. The company has a debt-to-equity ratio of 0.30, a quick ratio of 0.92 and a current ratio of 1.63. Henry Schein has a 52-week low of $56.58 and a 52-week high of $72.81. The firm has a market capitalization of $10.30 billion, a P/E ratio of 21.73, a P/E/G ratio of 2.14 and a beta of 0.85. The stock has a fifty day moving average price of $68.82 and a two-hundred day moving average price of $65.77.

Henry Schein declared that its board has approved a share buyback program on Thursday, October 31st that authorizes the company to repurchase $400.00 million in outstanding shares. This repurchase authorization authorizes the company to purchase up to 4.3% of its stock through open market purchases. Stock repurchase programs are usually an indication that the company’s management believes its stock is undervalued.

Hedge funds have recently bought and sold shares of the stock. NEXT Financial Group Inc increased its position in shares of Henry Schein by 67.3% during the fourth quarter. NEXT Financial Group Inc now owns 378 shares of the company’s stock worth $25,000 after acquiring an additional 152 shares during the period. Enterprise Financial Services Corp grew its stake in Henry Schein by 101.3% in the third quarter. Enterprise Financial Services Corp now owns 483 shares of the company’s stock worth $31,000 after purchasing an additional 243 shares in the last quarter. Cullen Frost Bankers Inc. grew its stake in Henry Schein by 153.1% in the fourth quarter. Cullen Frost Bankers Inc. now owns 496 shares of the company’s stock worth $33,000 after purchasing an additional 300 shares in the last quarter. Parallel Advisors LLC increased its holdings in Henry Schein by 50.3% during the 4th quarter. Parallel Advisors LLC now owns 923 shares of the company’s stock worth $61,000 after purchasing an additional 309 shares during the period. Finally, Quest Capital Management Inc. ADV purchased a new position in Henry Schein during the 3rd quarter worth $65,000.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Recommended Story: Beige Book

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.